Ensign Peak Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $560K | Sell |
|
|||||
|
2025
Q2 | $696K | Sell |
|
|||||
|
2025
Q1 | $818K | Hold |
|
|||||
|
2024
Q4 | $675K | Hold |
|
|||||
|
2024
Q3 | $729K | Hold |
|
|||||
|
2024
Q2 | $778K | Hold |
|
|||||
|
2024
Q1 | $845K | Sell |
|
|||||
|
2023
Q4 | $708K | Hold |
|
|||||
|
2023
Q3 | $745K | Hold |
|
|||||
|
2023
Q2 | $691K | Buy |
|
|||||
|
2023
Q1 | $478K | Buy |
|
|||||
|
2022
Q4 | $464K | Buy |
|
|||||
|
2022
Q3 | $232K | Sell |
|
|||||
|
2022
Q2 | $231K | Hold |
|
|||||
|
2022
Q1 | $219K | Hold |
|
|||||
|
2021
Q4 | $359K | Sell |
|
|||||
|
2021
Q3 | $433K | Hold |
|
|||||
|
2021
Q2 | $462K | Hold |
|
|||||
|
2021
Q1 | $476K | Hold |
|
|||||
|
2020
Q4 | $383K | Hold |
|
|||||
|
2020
Q3 | $372K | Hold |
|
|||||
|
2020
Q2 | $426K | Hold |
|
|||||
|
2020
Q1 | $537K | Hold |
|
|||||
|
2019
Q4 | $813K | Buy |
|